Skip links

PEGS 2023 Boston, May 15-19, 2023, Boston, MA, US

Join our CTO Alexander Schinagl at PEGS Boston. OncoOne is excited to present our latest research on “Pretargeted Radioimmunotherapy with an Anti-oxMIF/HSG Bispecific Antibody Demonstrates Efficacy in Murine Models of Cancer” at PEGS23. The study highlights the potential of our innovative PreTarg-it® platform combining a bispecific antibody and radioligand for targeting and treating solid tumors.

Home